Researchers in Thailand say that they have developed a prototype vaccine that will protect against dengue fever. The researchers will embark on further tests with the goal of bringing the vaccine to market within the next decade, AFP reports. The vaccine was developed jointly by scientists from Thailand’s Mahidol University, Chiang Mai University and the government’s National Center for Genetic Engineering and Biotechnology, according to AFP. “It’s the first time in Thailand that we created a prototype vaccine against dengue that has the attributes we wanted,” Nopporn Sithisombat, an associate professor at Chiang Mai University in northern Thailand, said, according to AFP. “Our goal is to create a vaccine against dengue fever in children.” The vaccine has so far been tested on monkeys and mice. Human trials will be the next step. There is no known treatment for dengue fever, which causes a severe flu-like illness for many of its victims. One of its...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




